The Clinical Benefit of an Artificial Intelligence Software Implementation on Diabetic Retinopathy Screening
The Clinical Benefit of an Artificial Intelligence Software Implementation on Diabetic Retinopathy Screening
The investigators aim to improve the diagnostic accuracy and the clinical referral rate for diabetic retinopathy by using a deep learning-based software.
Diabetic retinopathy (DR) is the leading cause of blindness among working-age patients with type 2 diabetes. According to previous studies, early screening and timely treatment can reduce the risk of worsening DR and blindness. International guidelines recommend that screening for DR be performed at least once every year for patients with type 2 diabetes. The investigators will implement a validated deep learning-based software, VeriSee®, in clinics, and evaluate the benefits on diagnostic accuracy and the clinical referral rate for diabetic retinopathy after implementation of this software.
Inclusion Criteria:
Exclusion Criteria:
itlee@vghtc.gov.tw+886-4-23592525 ext. 3070